primary dysmenorrhea
Conditions
Interventions
treatment group:penetrating method form Zhibian (BL54) to Shuidao (St28)
control group:ibuprofen capsules
Sponsors
Shanxi University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. Aged from 18 to 35 years without history of delivery; 2. Normal menstrual cycle (28+/-7 days) during the last 3 months; 3. Diagnosed with PD according to the Primary Dysmenorrhea Consensus Guidelines; 4. Menstrual pain scored > 40 mm on the Visual Analog Scale (VAS); 5. Agree with all procedures in this trial by signing a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Secondary dysmenorrhea caused by gynecological problems confirmed by Obstetrician visit or gynecological abdominal ultrasound B examination; 2. Serious contraindications such as progressive central nervous disorder, AID, spsychiatric disorders, malignant hypertension, hematological diseases, hepatic insufficiency; 3. Having the disease of peptic ulcer; 4. Receiving or having received any other treatment for PD in the previous15days; 5. Having the allergic history to aspirin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale;Cox Menstrual Symptom Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemorheology; | — |
Countries
China
Contacts
Public ContactLaixi Ji
Shanxi University of Chinese Medicine
Outcome results
None listed